Literature DB >> 8582388

Reproducibility of the signal-averaged electrocardiogram using individual lead analysis.

J Aganauskiene1, L Sörnmo, R Atarius, C Blomström-Lundqvist.   

Abstract

The aim of the study was to evaluate the immediate reproducibility of time domain parameters in the signal averaged electrocardiogram using a new method for endpoint determination in individual Frank leads. The method is based on a statistical model of the electrocardiogram (ECG) in which maximum likelihood (ML) estimation is employed. The reproducibility of the ML method was compared to that of conventional time domain analysis using the vector magnitude (VM) of Frank leads. Fifty-nine patients were included in the study and two consecutive ECGs were recorded for signal averaging. The results showed that the mean of the absolute difference of the filtered QRS duration (QRSD) between two consecutive recordings was significantly lower for the ML method than the conventional method when employing 60 Hz highpass filtering (2.1 +/- 2.2 ms vs 5.9 +/- 10.2 ms, P < 0.05). Moreover, the ML method resulted in a significantly longer QRSD compared to the VM-based method (P < 0.05). The terminal amplitude of the QRS complex (RMS40) showed a greater variability than the QRSD for both methods, although the ML method was associated with a higher reproducibility than the VM method for the 60 Hz filter. These findings may contribute to a better identification of patients at high risk of ventricular arrhythmias. A reduction in the number of measurement errors has important implications when QRS changes are analysed over time.

Entities:  

Mesh:

Year:  1995        PMID: 8582388     DOI: 10.1093/oxfordjournals.eurheartj.a061082

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  1 in total

1.  Signal-averaged electrocardiography in normal newborn infants.

Authors:  R G Bennhagen; L Sörnmo; O Pahlm; E Pesonen
Journal:  Pediatr Cardiol       Date:  2004-04-19       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.